カテゴリ： GlobalInfoResearch, 世界, 部品/材料

世界のカルバペネムAPI市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Carbapenem API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO2420）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO2420
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：化学＆材料
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のカルバペネムAPI市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

カルバペネムAPI市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のカルバペネムAPIの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

カルバペネムAPI市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・エルタペネム原薬、イミペネム原薬、メロペネム原薬、その他

用途別セグメントは次のように区分されます。
・静脈注射、筋肉注射

世界のカルバペネムAPI市場の主要な市場プレーヤーは以下のとおりです。
・ACS Dobfar、Savior Lifetec Corporation、Sumitomo Chemical Company、Shenzhen Haibin Pharmaceutical、Zhuhai United Laboratories、Zhejiang Hisun Pharmaceutical、Zhejiang Jiuzhou Pharmaceutical、Sun Pharma、Kopran、Hainan Haiyao、Zhejiang Hisoar、Kaliberr Labs、Jeil Pharmaceutical、Qilu Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、カルバペネムAPI製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なカルバペネムAPIメーカーの企業概要、2019年～2022年までのカルバペネムAPIの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なカルバペネムAPIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別カルバペネムAPIの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのカルバペネムAPIの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのカルバペネムAPI市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびカルバペネムAPIの産業チェーンを掲載しています。
・第13、14、15章では、カルバペネムAPIの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- カルバペネムAPIの概要
- 種類別分析（2017年vs2021年vs2028年）：エルタペネム原薬、イミペネム原薬、メロペネム原薬、その他
- 用途別分析（2017年vs2021年vs2028年）：静脈注射、筋肉注射
- 世界のカルバペネムAPI市場規模・予測
- 世界のカルバペネムAPI生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- ACS Dobfar、Savior Lifetec Corporation、Sumitomo Chemical Company、Shenzhen Haibin Pharmaceutical、Zhuhai United Laboratories、Zhejiang Hisun Pharmaceutical、Zhejiang Jiuzhou Pharmaceutical、Sun Pharma、Kopran、Hainan Haiyao、Zhejiang Hisoar、Kaliberr Labs、Jeil Pharmaceutical、Qilu Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：エルタペネム原薬、イミペネム原薬、メロペネム原薬、その他
・用途別分析2017年-2028年：静脈注射、筋肉注射
・カルバペネムAPIの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・カルバペネムAPIのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・カルバペネムAPIのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・カルバペネムAPIの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・カルバペネムAPIの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Carbapenem API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Carbapenem API market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Intravenous Injection accounting for % of the Carbapenem API global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Ertapenem API segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Carbapenem API include ACS Dobfar, Savior Lifetec Corporation, Sumitomo Chemical Company, Shenzhen Haibin Pharmaceutical, and Zhuhai United Laboratories, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Carbapenem API market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ertapenem API
Imipenem API
Meropenem API
Others
Market segment by Application can be divided into
Intravenous Injection
Intramuscular Injection
The key market players for global Carbapenem API market are listed below:
ACS Dobfar
Savior Lifetec Corporation
Sumitomo Chemical Company
Shenzhen Haibin Pharmaceutical
Zhuhai United Laboratories
Zhejiang Hisun Pharmaceutical
Zhejiang Jiuzhou Pharmaceutical
Sun Pharma
Kopran
Hainan Haiyao
Zhejiang Hisoar
Kaliberr Labs
Jeil Pharmaceutical
Qilu Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Carbapenem API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Carbapenem API, with price, sales, revenue and global market share of Carbapenem API from 2019 to 2022.
Chapter 3, the Carbapenem API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Carbapenem API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Carbapenem API market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Carbapenem API.
Chapter 13, 14, and 15, to describe Carbapenem API sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Carbapenem API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Carbapenem API Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Ertapenem API
1.2.3 Imipenem API
1.2.4 Meropenem API
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Carbapenem API Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Intravenous Injection
1.3.3 Intramuscular Injection
1.4 Global Carbapenem API Market Size & Forecast
1.4.1 Global Carbapenem API Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Carbapenem API Sales in Volume (2017-2028)
1.4.3 Global Carbapenem API Price (2017-2028)
1.5 Global Carbapenem API Production Capacity Analysis
1.5.1 Global Carbapenem API Total Production Capacity (2017-2028)
1.5.2 Global Carbapenem API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Carbapenem API Market Drivers
1.6.2 Carbapenem API Market Restraints
1.6.3 Carbapenem API Trends Analysis
2 Manufacturers Profiles
2.1 ACS Dobfar
2.1.1 ACS Dobfar Details
2.1.2 ACS Dobfar Major Business
2.1.3 ACS Dobfar Carbapenem API Product and Services
2.1.4 ACS Dobfar Carbapenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Savior Lifetec Corporation
2.2.1 Savior Lifetec Corporation Details
2.2.2 Savior Lifetec Corporation Major Business
2.2.3 Savior Lifetec Corporation Carbapenem API Product and Services
2.2.4 Savior Lifetec Corporation Carbapenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sumitomo Chemical Company
2.3.1 Sumitomo Chemical Company Details
2.3.2 Sumitomo Chemical Company Major Business
2.3.3 Sumitomo Chemical Company Carbapenem API Product and Services
2.3.4 Sumitomo Chemical Company Carbapenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Shenzhen Haibin Pharmaceutical
2.4.1 Shenzhen Haibin Pharmaceutical Details
2.4.2 Shenzhen Haibin Pharmaceutical Major Business
2.4.3 Shenzhen Haibin Pharmaceutical Carbapenem API Product and Services
2.4.4 Shenzhen Haibin Pharmaceutical Carbapenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Zhuhai United Laboratories
2.5.1 Zhuhai United Laboratories Details
2.5.2 Zhuhai United Laboratories Major Business
2.5.3 Zhuhai United Laboratories Carbapenem API Product and Services
2.5.4 Zhuhai United Laboratories Carbapenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Zhejiang Hisun Pharmaceutical
2.6.1 Zhejiang Hisun Pharmaceutical Details
2.6.2 Zhejiang Hisun Pharmaceutical Major Business
2.6.3 Zhejiang Hisun Pharmaceutical Carbapenem API Product and Services
2.6.4 Zhejiang Hisun Pharmaceutical Carbapenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Zhejiang Jiuzhou Pharmaceutical
2.7.1 Zhejiang Jiuzhou Pharmaceutical Details
2.7.2 Zhejiang Jiuzhou Pharmaceutical Major Business
2.7.3 Zhejiang Jiuzhou Pharmaceutical Carbapenem API Product and Services
2.7.4 Zhejiang Jiuzhou Pharmaceutical Carbapenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sun Pharma
2.8.1 Sun Pharma Details
2.8.2 Sun Pharma Major Business
2.8.3 Sun Pharma Carbapenem API Product and Services
2.8.4 Sun Pharma Carbapenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Kopran
2.9.1 Kopran Details
2.9.2 Kopran Major Business
2.9.3 Kopran Carbapenem API Product and Services
2.9.4 Kopran Carbapenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Hainan Haiyao
2.10.1 Hainan Haiyao Details
2.10.2 Hainan Haiyao Major Business
2.10.3 Hainan Haiyao Carbapenem API Product and Services
2.10.4 Hainan Haiyao Carbapenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Zhejiang Hisoar
2.11.1 Zhejiang Hisoar Details
2.11.2 Zhejiang Hisoar Major Business
2.11.3 Zhejiang Hisoar Carbapenem API Product and Services
2.11.4 Zhejiang Hisoar Carbapenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Kaliberr Labs
2.12.1 Kaliberr Labs Details
2.12.2 Kaliberr Labs Major Business
2.12.3 Kaliberr Labs Carbapenem API Product and Services
2.12.4 Kaliberr Labs Carbapenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Jeil Pharmaceutical
2.13.1 Jeil Pharmaceutical Details
2.13.2 Jeil Pharmaceutical Major Business
2.13.3 Jeil Pharmaceutical Carbapenem API Product and Services
2.13.4 Jeil Pharmaceutical Carbapenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Qilu Pharmaceutical
2.14.1 Qilu Pharmaceutical Details
2.14.2 Qilu Pharmaceutical Major Business
2.14.3 Qilu Pharmaceutical Carbapenem API Product and Services
2.14.4 Qilu Pharmaceutical Carbapenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Carbapenem API Breakdown Data by Manufacturer
3.1 Global Carbapenem API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Carbapenem API Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Carbapenem API
3.4 Market Concentration Rate
3.4.1 Top 3 Carbapenem API Manufacturer Market Share in 2021
3.4.2 Top 6 Carbapenem API Manufacturer Market Share in 2021
3.5 Global Carbapenem API Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Carbapenem API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Carbapenem API Market Size by Region
4.1.1 Global Carbapenem API Sales in Volume by Region (2017-2028)
4.1.2 Global Carbapenem API Revenue by Region (2017-2028)
4.2 North America Carbapenem API Revenue (2017-2028)
4.3 Europe Carbapenem API Revenue (2017-2028)
4.4 Asia-Pacific Carbapenem API Revenue (2017-2028)
4.5 South America Carbapenem API Revenue (2017-2028)
4.6 Middle East and Africa Carbapenem API Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Carbapenem API Sales in Volume by Type (2017-2028)
5.2 Global Carbapenem API Revenue by Type (2017-2028)
5.3 Global Carbapenem API Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Carbapenem API Sales in Volume by Application (2017-2028)
6.2 Global Carbapenem API Revenue by Application (2017-2028)
6.3 Global Carbapenem API Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Carbapenem API Sales by Type (2017-2028)
7.2 North America Carbapenem API Sales by Application (2017-2028)
7.3 North America Carbapenem API Market Size by Country
7.3.1 North America Carbapenem API Sales in Volume by Country (2017-2028)
7.3.2 North America Carbapenem API Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Carbapenem API Sales by Type (2017-2028)
8.2 Europe Carbapenem API Sales by Application (2017-2028)
8.3 Europe Carbapenem API Market Size by Country
8.3.1 Europe Carbapenem API Sales in Volume by Country (2017-2028)
8.3.2 Europe Carbapenem API Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Carbapenem API Sales by Type (2017-2028)
9.2 Asia-Pacific Carbapenem API Sales by Application (2017-2028)
9.3 Asia-Pacific Carbapenem API Market Size by Region
9.3.1 Asia-Pacific Carbapenem API Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Carbapenem API Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Carbapenem API Sales by Type (2017-2028)
10.2 South America Carbapenem API Sales by Application (2017-2028)
10.3 South America Carbapenem API Market Size by Country
10.3.1 South America Carbapenem API Sales in Volume by Country (2017-2028)
10.3.2 South America Carbapenem API Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Carbapenem API Sales by Type (2017-2028)
11.2 Middle East & Africa Carbapenem API Sales by Application (2017-2028)
11.3 Middle East & Africa Carbapenem API Market Size by Country
11.3.1 Middle East & Africa Carbapenem API Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Carbapenem API Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Carbapenem API and Key Manufacturers
12.2 Manufacturing Costs Percentage of Carbapenem API
12.3 Carbapenem API Production Process
12.4 Carbapenem API Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Carbapenem API Typical Distributors
13.3 Carbapenem API Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Carbapenem API Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Carbapenem API Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. ACS Dobfar Basic Information, Manufacturing Base and Competitors
Table 4. ACS Dobfar Major Business
Table 5. ACS Dobfar Carbapenem API Product and Services
Table 6. ACS Dobfar Carbapenem API Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Savior Lifetec Corporation Basic Information, Manufacturing Base and Competitors
Table 8. Savior Lifetec Corporation Major Business
Table 9. Savior Lifetec Corporation Carbapenem API Product and Services
Table 10. Savior Lifetec Corporation Carbapenem API Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sumitomo Chemical Company Basic Information, Manufacturing Base and Competitors
Table 12. Sumitomo Chemical Company Major Business
Table 13. Sumitomo Chemical Company Carbapenem API Product and Services
Table 14. Sumitomo Chemical Company Carbapenem API Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Shenzhen Haibin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Shenzhen Haibin Pharmaceutical Major Business
Table 17. Shenzhen Haibin Pharmaceutical Carbapenem API Product and Services
Table 18. Shenzhen Haibin Pharmaceutical Carbapenem API Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Zhuhai United Laboratories Basic Information, Manufacturing Base and Competitors
Table 20. Zhuhai United Laboratories Major Business
Table 21. Zhuhai United Laboratories Carbapenem API Product and Services
Table 22. Zhuhai United Laboratories Carbapenem API Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Zhejiang Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Zhejiang Hisun Pharmaceutical Major Business
Table 25. Zhejiang Hisun Pharmaceutical Carbapenem API Product and Services
Table 26. Zhejiang Hisun Pharmaceutical Carbapenem API Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Zhejiang Jiuzhou Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Zhejiang Jiuzhou Pharmaceutical Major Business
Table 29. Zhejiang Jiuzhou Pharmaceutical Carbapenem API Product and Services
Table 30. Zhejiang Jiuzhou Pharmaceutical Carbapenem API Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Sun Pharma Major Business
Table 33. Sun Pharma Carbapenem API Product and Services
Table 34. Sun Pharma Carbapenem API Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Kopran Basic Information, Manufacturing Base and Competitors
Table 36. Kopran Major Business
Table 37. Kopran Carbapenem API Product and Services
Table 38. Kopran Carbapenem API Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Hainan Haiyao Basic Information, Manufacturing Base and Competitors
Table 40. Hainan Haiyao Major Business
Table 41. Hainan Haiyao Carbapenem API Product and Services
Table 42. Hainan Haiyao Carbapenem API Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Zhejiang Hisoar Basic Information, Manufacturing Base and Competitors
Table 44. Zhejiang Hisoar Major Business
Table 45. Zhejiang Hisoar Carbapenem API Product and Services
Table 46. Zhejiang Hisoar Carbapenem API Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Kaliberr Labs Basic Information, Manufacturing Base and Competitors
Table 48. Kaliberr Labs Major Business
Table 49. Kaliberr Labs Carbapenem API Product and Services
Table 50. Kaliberr Labs Carbapenem API Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Jeil Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Jeil Pharmaceutical Major Business
Table 53. Jeil Pharmaceutical Carbapenem API Product and Services
Table 54. Jeil Pharmaceutical Carbapenem API Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. Qilu Pharmaceutical Major Business
Table 57. Qilu Pharmaceutical Carbapenem API Product and Services
Table 58. Qilu Pharmaceutical Carbapenem API Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Carbapenem API Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Ton)
Table 60. Global Carbapenem API Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Carbapenem API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Carbapenem API Production Capacity by Company, (Ton): 2020 VS 2021
Table 63. Head Office and Carbapenem API Production Site of Key Manufacturer
Table 64. Carbapenem API New Entrant and Capacity Expansion Plans
Table 65. Carbapenem API Mergers & Acquisitions in the Past Five Years
Table 66. Global Carbapenem API Sales by Region (2017-2022) & (Ton)
Table 67. Global Carbapenem API Sales by Region (2023-2028) & (Ton)
Table 68. Global Carbapenem API Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Carbapenem API Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Carbapenem API Sales by Type (2017-2022) & (Ton)
Table 71. Global Carbapenem API Sales by Type (2023-2028) & (Ton)
Table 72. Global Carbapenem API Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Carbapenem API Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Carbapenem API Price by Type (2017-2022) & (US$/Ton)
Table 75. Global Carbapenem API Price by Type (2023-2028) & (US$/Ton)
Table 76. Global Carbapenem API Sales by Application (2017-2022) & (Ton)
Table 77. Global Carbapenem API Sales by Application (2023-2028) & (Ton)
Table 78. Global Carbapenem API Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Carbapenem API Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Carbapenem API Price by Application (2017-2022) & (US$/Ton)
Table 81. Global Carbapenem API Price by Application (2023-2028) & (US$/Ton)
Table 82. North America Carbapenem API Sales by Country (2017-2022) & (Ton)
Table 83. North America Carbapenem API Sales by Country (2023-2028) & (Ton)
Table 84. North America Carbapenem API Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Carbapenem API Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Carbapenem API Sales by Type (2017-2022) & (Ton)
Table 87. North America Carbapenem API Sales by Type (2023-2028) & (Ton)
Table 88. North America Carbapenem API Sales by Application (2017-2022) & (Ton)
Table 89. North America Carbapenem API Sales by Application (2023-2028) & (Ton)
Table 90. Europe Carbapenem API Sales by Country (2017-2022) & (Ton)
Table 91. Europe Carbapenem API Sales by Country (2023-2028) & (Ton)
Table 92. Europe Carbapenem API Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Carbapenem API Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Carbapenem API Sales by Type (2017-2022) & (Ton)
Table 95. Europe Carbapenem API Sales by Type (2023-2028) & (Ton)
Table 96. Europe Carbapenem API Sales by Application (2017-2022) & (Ton)
Table 97. Europe Carbapenem API Sales by Application (2023-2028) & (Ton)
Table 98. Asia-Pacific Carbapenem API Sales by Region (2017-2022) & (Ton)
Table 99. Asia-Pacific Carbapenem API Sales by Region (2023-2028) & (Ton)
Table 100. Asia-Pacific Carbapenem API Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Carbapenem API Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Carbapenem API Sales by Type (2017-2022) & (Ton)
Table 103. Asia-Pacific Carbapenem API Sales by Type (2023-2028) & (Ton)
Table 104. Asia-Pacific Carbapenem API Sales by Application (2017-2022) & (Ton)
Table 105. Asia-Pacific Carbapenem API Sales by Application (2023-2028) & (Ton)
Table 106. South America Carbapenem API Sales by Country (2017-2022) & (Ton)
Table 107. South America Carbapenem API Sales by Country (2023-2028) & (Ton)
Table 108. South America Carbapenem API Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Carbapenem API Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Carbapenem API Sales by Type (2017-2022) & (Ton)
Table 111. South America Carbapenem API Sales by Type (2023-2028) & (Ton)
Table 112. South America Carbapenem API Sales by Application (2017-2022) & (Ton)
Table 113. South America Carbapenem API Sales by Application (2023-2028) & (Ton)
Table 114. Middle East & Africa Carbapenem API Sales by Region (2017-2022) & (Ton)
Table 115. Middle East & Africa Carbapenem API Sales by Region (2023-2028) & (Ton)
Table 116. Middle East & Africa Carbapenem API Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Carbapenem API Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Carbapenem API Sales by Type (2017-2022) & (Ton)
Table 119. Middle East & Africa Carbapenem API Sales by Type (2023-2028) & (Ton)
Table 120. Middle East & Africa Carbapenem API Sales by Application (2017-2022) & (Ton)
Table 121. Middle East & Africa Carbapenem API Sales by Application (2023-2028) & (Ton)
Table 122. Carbapenem API Raw Material
Table 123. Key Manufacturers of Carbapenem API Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Carbapenem API Typical Distributors
Table 127. Carbapenem API Typical Customers
List of Figures
Figure 1. Carbapenem API Picture
Figure 2. Global Carbapenem API Revenue Market Share by Type in 2021
Figure 3. Ertapenem API
Figure 4. Imipenem API
Figure 5. Meropenem API
Figure 6. Others
Figure 7. Global Carbapenem API Revenue Market Share by Application in 2021
Figure 8. Intravenous Injection
Figure 9. Intramuscular Injection
Figure 10. Global Carbapenem API Revenue, (USD Million) & (Ton): 2017 & 2021 & 2028
Figure 11. Global Carbapenem API Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Carbapenem API Sales (2017-2028) & (Ton)
Figure 13. Global Carbapenem API Price (2017-2028) & (US$/Ton)
Figure 14. Global Carbapenem API Production Capacity (2017-2028) & (Ton)
Figure 15. Global Carbapenem API Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Carbapenem API Market Drivers
Figure 17. Carbapenem API Market Restraints
Figure 18. Carbapenem API Market Trends
Figure 19. Global Carbapenem API Sales Market Share by Manufacturer in 2021
Figure 20. Global Carbapenem API Revenue Market Share by Manufacturer in 2021
Figure 21. Carbapenem API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Carbapenem API Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Carbapenem API Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Carbapenem API Sales Market Share by Region (2017-2028)
Figure 25. Global Carbapenem API Revenue Market Share by Region (2017-2028)
Figure 26. North America Carbapenem API Revenue (2017-2028) & (USD Million)
Figure 27. Europe Carbapenem API Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Carbapenem API Revenue (2017-2028) & (USD Million)
Figure 29. South America Carbapenem API Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Carbapenem API Revenue (2017-2028) & (USD Million)
Figure 31. Global Carbapenem API Sales Market Share by Type (2017-2028)
Figure 32. Global Carbapenem API Revenue Market Share by Type (2017-2028)
Figure 33. Global Carbapenem API Price by Type (2017-2028) & (US$/Ton)
Figure 34. Global Carbapenem API Sales Market Share by Application (2017-2028)
Figure 35. Global Carbapenem API Revenue Market Share by Application (2017-2028)
Figure 36. Global Carbapenem API Price by Application (2017-2028) & (US$/Ton)
Figure 37. North America Carbapenem API Sales Market Share by Type (2017-2028)
Figure 38. North America Carbapenem API Sales Market Share by Application (2017-2028)
Figure 39. North America Carbapenem API Sales Market Share by Country (2017-2028)
Figure 40. North America Carbapenem API Revenue Market Share by Country (2017-2028)
Figure 41. United States Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Carbapenem API Sales Market Share by Type (2017-2028)
Figure 45. Europe Carbapenem API Sales Market Share by Application (2017-2028)
Figure 46. Europe Carbapenem API Sales Market Share by Country (2017-2028)
Figure 47. Europe Carbapenem API Revenue Market Share by Country (2017-2028)
Figure 48. Germany Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Carbapenem API Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Carbapenem API Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Carbapenem API Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Carbapenem API Revenue Market Share by Region (2017-2028)
Figure 57. China Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Carbapenem API Sales Market Share by Type (2017-2028)
Figure 64. South America Carbapenem API Sales Market Share by Application (2017-2028)
Figure 65. South America Carbapenem API Sales Market Share by Country (2017-2028)
Figure 66. South America Carbapenem API Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Carbapenem API Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Carbapenem API Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Carbapenem API Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Carbapenem API Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Carbapenem API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Carbapenem API in 2021
Figure 78. Manufacturing Process Analysis of Carbapenem API
Figure 79. Carbapenem API Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のカルバペネム系抗生物質市場2022年：市場規模予測（～2028年）
  • 世界の医薬品包装用接着剤市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用ニコチンアミド市場2022年：市場規模予測（～2028年）
  • 世界の抗生物質医薬品有効成分(API)市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用二酸化チタン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO2420 )"世界のカルバペネムAPI市場2022年：市場規模予測（～2028年）" (英文：Global Carbapenem API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。